drugset
drugset / Trial / NCT03849495

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults

NCT03849495 ↗

Phase 1 Unknown 28 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single dose, two-way crossover study to compare the pharmacokinetics and safety/tolerability of CKD-370 with D745 in healthy volunteers

Timeline

Start
2019-02-19
Primary completion
2019-03-17
Completion
2019-03-21

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-370 Unknown — —
Subject D745 Unknown — —

Indications

type 2 diabetes mellitus